| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | -0.025 | 0.9 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | -0.022 | 0.9 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |